PHILADELPHIA, March 1, 2011 /PRNewswire/ -- ERT (Nasdaq: ERES), a global technology-driven provider of clinical services and customizable medical devices to bio-pharmaceutical and healthcare organizations, announced today that the Nasdaq Stock Market has approved a change in the Company's trading symbol. ERT will trade on the Nasdaq Global Select Market under the symbol "ERT" effective March 7, 2011. Stockholders are advised to make note of this trading symbol change.
"ERT has evolved as a strong brand under which we operate, and this change to our trading symbol is intended to properly align our business brand with the investment community," said Joel Morganroth, Chief Executive Officer of ERT.
For further press information, please contact Fiona Robinson, The Scott Partnership, One Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom. Phone +44 1477 539539, Fax +44 1477 539540, email email@example.com.
ERT (www.ert.com) is a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations. It is the market leader for centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes electronic Patient Reported Outcomes (ePRO) in multiple modalities across all phases of clinical research.